https://mazenz.com/Newsemia/2018/11/13/predicted-antiviral-activity-of-tenofovir-versus-abacavir-in-combination-with-a-cytosine-analogue-and-the-integrase-inhibitor-dolutegravir-in-hiv-1-infected-south-african-patients-initiating-or-failin/
Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART